Search Results - "Johnson, Philip James"

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma by Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke, Tsumura, Hidetaka, Kuzuya, Teiji, Isoda, Norio, Moriguchi, Michihisa, Aino, Hajime, Ido, Akio, Kawabe, Naoto, Nakao, Kazuhiko, Wada, Yoshiyuki, Ogasawara, Sadahisa, Yoshimura, Kenichi, Okusaka, Takuji, Furuse, Junji, Kokudo, Norihiro, Okita, Kiwamu, Johnson, Philip James, Arai, Yasuaki

“…Introduction: Several clinical trials comparing the efficacy and safety of transarterial chemoembolization (TACE) plus molecular-targeted agents versus TACE…”
Get full text

A Comprehensive Karyotypic Study on Human Hepatocellular Carcinoma by Spectral Karyotyping by Wong, Nathalie, Lai, Paul, Pang, Elizabeth, Wai-Tong Leung, Thomas, Wan-Yee Lau, Joseph, James Johnson, Philip

“…The current paucity of cytogenetic information on hepatocellular carcinoma (HCC) reflects the difficulties in culturing hepatocytes in vitro. Here, we report…”
Get full text

Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications by Teo, P M, Leung, S F, Chan, A T, Leung, T W, Choi, P H, Kwan, W H, Lee, W Y, Chau, R M, Yu, P K, Johnson, P J

“…The aim of the present study was to compare the survival, local control and complications of conventional/accelerated-hyperfractionated radiotherapy and…”
Get more information

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial by Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke, Tsumura, Hidetaka, Kuzuya, Teiji, Isoda, Norio, Yasui, Kohichiroh, Aino, Hajime, Ido, Akio, Kawabe, Naoto, Nakao, Kazuhiko, Wada, Yoshiyuki, Yokosuka, Osamu, Yoshimura, Kenichi, Okusaka, Takuji, Furuse, Junji, Kokudo, Norihiro, Okita, Kiwamu, Johnson, Philip James, Arai, Yasuaki

“…This trial compared the efficacy and safety of transarterial chemoembolisation (TACE) plus sorafenib with TACE alone using a newly established TACE-specific…”
Get more information

Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma by Johnson, Philip James, Pinato, David J., Kalyuzhnyy, Anton, Toyoda, Hidenori

Get full text

Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy by Teo, P M, Chan, A T, Lee, W Y, Leung, T W, Johnson, P J

“…To determine the efficacy of chemotherapy adjunctive to radical radiotherapy (neoadjuvant +/- adjuvant) in patients with node-positive nasopharyngeal carcinoma…”
Get more information

Aggressive primary hepatic lymphoma in Chinese patients. Presentation, pathologic features, and outcome by Lei, K I, Chow, J H, Johnson, P J

“…Primary non-Hodgkin's lymphoma of the liver is rare. In this study, the presentation, pathologic features, and outcome of seven Chinese patients with primary…”
Get more information

Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma by Johnson, Philip James, Pinato, David J, Kalyuzhnyy, Anton, Toyoda, Hidenori

Get full text

The use of AFP and DCP as serum biomarkers to differentiate between hepatocellular carcinoma and intrahepatic cholangiocarcinoma in non-cirrhotic livers by Nathavitharana, Ravindhi Lakmalee, Teng, Mabel Joey, Johnson, Philip James, Berhane, Sarah, Skowronska, Anna, Morse, Janet

“…Abstract only e15162 Background: Differential diagnosis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) can be challenging in…”
Get full text

The impact of diabetes on HCC by Graef, Suzanne, Berhane, Sarah, Teng, Mabel Joey, Skowronska, Anna, Johnson, Philip James

“…Abstract only 4029 Background: The incidence of hepatocellular carcinoma (HCC) in the UK has increased by 40% over the last 20 years, with a corresponding…”
Get full text

Assessment of prognosis in hepatocellular carcinoma (HCC) using biomarkers and serum measurements by Teng, Mabel Joey, Nathavitharana, Ravindhi Lakmalee, Fox, Richard, Berhane, Sarah, Skowronska, Anna, Johnson, Philip James

“…Abstract only e15093 Background: Factors that influence prognosis in HCC are well-recognised. They include tumour size and number, the severity of liver…”
Get full text

TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC)—Background by Meyer, Tim, Fox, Richard, Ma, Yuk Ting, Ross, Paul J., James, Martin, Strugess, Richard, Stubbs, Clive, Wall, Lucy, Watkinson, Anthony, Hacking, Nigel, Evans, T.R. Jeffry, Collins, Peter, Hubner, Richard, Cunningham, David, Primrose, John Neil, Johnson, Philip James, Palmer, Daniel H.

“…Abstract only…”
Get full text

Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization Analysis by Wong, Nathalie, Lai, Paul, Lee, Siu-Wah, Fan, Susanna, Pang, Elizabeth, Liew, Choong-Tsek, Sheng, Zhong, Lau, Joseph Wan-Yee, Johnson, Philip James

“…Hepatocellular carcinoma (HCC) is a common and highly malignant tumor that is prevalent in Southeast Asia. Although the etiological factors associated are now…”
Get full text

Glycosylation and cancer: A potential target for therapeutic intervention by Baldwin, Gouri, O'Sullivan, Brendan, Desai, Anant, Gourevitch, David, Woodman, Ciaran, Taniere, Philippe, Johnson, Philip James

“…Abstract only e13507 Background: Aberrant glycosylation is a hallmark of cancer progression. Altered expression of glycosyltransferases and molecular…”
Get full text

Gemcitabine chemotherapy until symptomatic disease progression in advanced pancreatic cancer: A retrospective analysis by Ma, Yuk Ting, Hussain, Syed A., Johnson, Philip James, Palmer, Daniel H.

“…Abstract only 372 Background: Gemcitabine was established as the standard first-line therapy for patients with advanced pancreatic cancer in 1997 after a…”
Get full text

A joint United Kingdom (UK) and Hong Kong (HK) study to determine prognostic factors for hepatocellular carcinoma (HCC) undergoing curative and palliative treatment by Chan, Stephen Lam, Johnson, Philip James, Mo, Frankie, Berhane, Sarah, Ma, Brigette, Teng, Mabel, Poon, Darren M. C., Morse, Janet, Chan, Anthony T. C., Yeo, Winnie

“…Abstract only 181 Background: There have been few international studies that systematically evaluate the impact of geographical region on the prognosis of HCC…”
Get full text

TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC) by Meyer, Tim, Fox, Richard, Bird, Deborah, Watkinson, Anthony, Hacking, Nigel, Stocken, Deborah, Johnson, Philip James, Palmer, Daniel H.

“…Abstract only TPS4150 Background: TACE is regarded as the standard of care for patients with intermediate stage HCC (BCLC B), while sorafenib (S) is the…”
Get full text

Assessment of liver dysfunction in hepatocellular carcinoma (HCC): An international collaborative study by Johnson, Philip James, Berhane, Sarah, Kagebayashi, Chiaki, Satomura, Shinji, Teng, Mabel Joey, Skowronska, Anna, Cox, Trevor F., Palmer, Daniel H., Yeo, Winnie, Mo, Frankie, Lai, Paul B. S., Iñarrairaegui, Mercedes, Chan, Stephen Lam, Sangro, Bruno, Tada, Toshifumi, Toyoda, Hidenori, Kumada, Takashi

“…Abstract only…”
Get full text

Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC bridge study: First characterization of the full study population by Park, Joong-Won, Sherman, Morris, Colombo, Massimo, Roberts, Lewis R., Schwartz, Myron E., Degos, Francoise, Chen, Pei-Jer, Chen, Minshan, Kudo, Masatoshi, Johnson, Philip James, Huang, Baisong, Orsini, Lucinda S.

“…Abstract only 4033 Background: HCC is a major health problem across the world. The global HCC BRIDGE study is the first global, large-scale, observational…”
Get full text

Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization Analysis : Relationship to Disease Stage, Tumor Size, and Cirrhosis by Wong, Nathalie, Lai, Paul, Lee, Siu-Wah, Fan, Susanna, Pang, Elizabeth, Liew, Choong-Tsek, Sheng, Zhong, Lau, Joseph Wan-Yee, Johnson, Philip James

“…Hepatocellular carcinoma (HCC) is a common and highly malignant tumor that is prevalent in Southeast Asia. Although the etiological factors associated are now…”
Get full text